I would suggest this pertains to using dermal matrices over more traditional surgical methods and not relating to synthetic vs non-synthetic costs debate. We already know this product is significantly cheaper than biologicals, I think they want larger multi-centre trials investigating cost-benefit ratios regarding synthetic use vs traditional methods which is commonplace for adopting a new product as status quo.
- Forums
- ASX - By Stock
- PNV Media Thread
I would suggest this pertains to using dermal matrices over more...
-
- There are more pages in this discussion • 2,319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.35 |
Change
0.075(3.30%) |
Mkt cap ! $1.615B |
Open | High | Low | Value | Volume |
$2.33 | $2.38 | $2.29 | $2.390M | 1.021M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 10442 | $2.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.35 | 39298 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 16841 | 2.340 |
34 | 77562 | 2.330 |
15 | 54274 | 2.320 |
11 | 23077 | 2.310 |
7 | 14527 | 2.300 |
Price($) | Vol. | No. |
---|---|---|
2.350 | 30532 | 14 |
2.360 | 45839 | 21 |
2.370 | 59113 | 16 |
2.380 | 48683 | 13 |
2.390 | 128338 | 8 |
Last trade - 13.04pm 26/06/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |